Lombard Odier Asset Management (Europe) LTD Maravai Lifesciences Holdings, Inc. Transaction History

Lombard Odier Asset Management (Europe) LTD

$1.57 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $70,500 - $148,050	15,000 Added 42.86%	50,000 $327,000
Q2 2023 Aug 14, 2023	SELL	$12.09 - $15.0 $24,180 - $30,000	-2,000 Reduced 5.41%	35,000 $435,000
Q1 2023 May 15, 2023	SELL	$12.99 - $16.48 $38,970 - $49,440	-3,000 Reduced 7.5%	37,000 $518,000
Q4 2022 Feb 14, 2023	SELL	$12.5 - $24.78 $37,500 - $74,340	-3,000 Reduced 6.98%	40,000 $572,000
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $41,200 - $60,740	-2,000 Reduced 4.44%	43,000 $1.1 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $1.17 Million - $1.69 Million	45,000 New	45,000 $1.28 Million

Others Institutions Holding MRVI

# of Institutions

234

Shares Held

140M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $723M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.

Account